ACHFF
Price
$1.29
Change
-$0.04 (-3.01%)
Updated
Jul 2 closing price
Capitalization
86.21M
INBX
Price
$16.33
Change
+$0.59 (+3.75%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
212.72M
47 days until earnings call
Interact to see
Advertisement

ACHFF vs INBX

Header iconACHFF vs INBX Comparison
Open Charts ACHFF vs INBXBanner chart's image
Arch Biopartners
Price$1.29
Change-$0.04 (-3.01%)
Volume$13.11K
Capitalization86.21M
Inhibrx Biosciences
Price$16.33
Change+$0.59 (+3.75%)
Volume$6.37K
Capitalization212.72M
ACHFF vs INBX Comparison Chart in %
Loading...
ACHFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHFF vs. INBX commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHFF is a Hold and INBX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (ACHFF: $1.29 vs. INBX: $15.70)
Brand notoriety: ACHFF and INBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHFF: 109% vs. INBX: 86%
Market capitalization -- ACHFF: $86.21M vs. INBX: $212.72M
ACHFF [@Biotechnology] is valued at $86.21M. INBX’s [@Biotechnology] market capitalization is $212.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHFF’s FA Score shows that 0 FA rating(s) are green whileINBX’s FA Score has 2 green FA rating(s).

  • ACHFF’s FA Score: 0 green, 5 red.
  • INBX’s FA Score: 2 green, 3 red.
According to our system of comparison, INBX is a better buy in the long-term than ACHFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHFF’s TA Score shows that 4 TA indicator(s) are bullish while INBX’s TA Score has 5 bullish TA indicator(s).

  • ACHFF’s TA Score: 4 bullish, 4 bearish.
  • INBX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INBX is a better buy in the short-term than ACHFF.

Price Growth

ACHFF (@Biotechnology) experienced а -6.52% price change this week, while INBX (@Biotechnology) price change was +5.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

INBX is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($213M) has a higher market cap than ACHFF($86.2M). INBX YTD gains are higher at: 1.948 vs. ACHFF (-4.444). INBX has higher annual earnings (EBITDA): 1.73B vs. ACHFF (-2.68M). INBX has more cash in the bank: 217M vs. ACHFF (10K). ACHFF has less debt than INBX: ACHFF (2.38M) vs INBX (107M). INBX has higher revenues than ACHFF: INBX (200K) vs ACHFF (0).
ACHFFINBXACHFF / INBX
Capitalization86.2M213M40%
EBITDA-2.68M1.73B-0%
Gain YTD-4.4441.948-228%
P/E RatioN/A0.12-
Revenue0200K-
Total Cash10K217M0%
Total Debt2.38M107M2%
FUNDAMENTALS RATINGS
ACHFF: Fundamental Ratings
ACHFF
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACHFFINBX
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ACHFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FYMNF0.07N/A
+1.71%
Finlay Minerals Ltd
ADOOY5.40N/A
N/A
PT ALAMTRI RES INDONESIA TBK
TRPCF56.84N/A
N/A
Trip.com Group Limited
EVTZF9.04-0.09
-0.99%
Evertz Technologies Ltd.
ARRNF0.16N/A
-2.91%
American Rare Earths Ltd.

ACHFF and

Correlation & Price change

A.I.dvisor tells us that ACHFF and LABFF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACHFF and LABFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHFF
1D Price
Change %
ACHFF100%
-3.01%
LABFF - ACHFF
21%
Poorly correlated
N/A
ARGNF - ACHFF
11%
Poorly correlated
+0.08%
AGTX - ACHFF
4%
Poorly correlated
N/A
ADCT - ACHFF
4%
Poorly correlated
+4.87%
INBX - ACHFF
3%
Poorly correlated
+7.02%
More

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+7.02%
AXON - INBX
48%
Loosely correlated
-0.09%
AKESF - INBX
45%
Loosely correlated
N/A
GBIO - INBX
40%
Loosely correlated
+5.59%
SNTI - INBX
39%
Loosely correlated
+2.74%
INVA - INBX
38%
Loosely correlated
-1.92%
More